This bill (A 565) prohibits the establishment of new for-profit hospices and bans capacity increases for existing for-profit hospices. It applies to all approvals after the law takes effect, directly affecting for-profit hospice providers and their expansion plans. The law requires new hospice facilities to operate as non-profits and prevents existing for-profit hospices from growing their services. This represents a concrete change in healthcare regulation, restricting for-profit models in hospice care.
Requires public notice and public engagement when a general hospital seeks to close entirely or a unit that provides maternity, mental health or substance use care.
S 123 bans the sale of infant walkers by all sellers (manufacturers, distributors, retailers, and secondhand dealers) in New York State. It also restricts the use of infant walkers in child care facilities, requiring medical necessity approval from a professional for any exception. Child care facilities must receive plain-language notice about the ban and follow rules set by the Office of Children and Family Services. The law allows the attorney general to enforce the ban through injunctions and impose civil penalties for violations.
This bill (S 3236) allows registered pharmacy technicians to work in any licensed pharmacy under the direct supervision of a licensed pharmacist. It permits technicians to assist with tasks like preparing, labeling, and dispensing prescriptions or medications - provided these tasks require no professional judgment (which remains the pharmacist's responsibility). The law requires pharmacists to be physically present during these tasks, authorize all work, and approve it before any medication is dispensed. The pharmacy must also ensure technicians receive proper training before they begin assisting. The bill is now law (signed November 21, 2025).
S 1720 would have required New York's public health department to launch an awareness campaign about hormone replacement therapy (HRT) for perimenopause and menopause symptoms. The campaign would have provided women directly affected by these symptoms with plain-language information on HRT benefits, risks, side effects, available types, and current medical recommendations. The bill specifically mandated that the campaign cover symptom management, health risks, and evidence-based usage guidelines for HRT. However, the bill was vetoed by the governor on October 16, 2025, so it did not become law.
This bill (S 1224) prevents school-based health center services from being delivered to medical assistance recipients (like Medicaid beneficiaries) through private managed care insurance plans. It amends state law to require these services to continue being provided directly outside of managed care programs. The key change ensures that students receiving medical assistance can access school health services through traditional public health channels, not through private insurance networks. The bill was passed by the legislature in June 2025 but was vetoed by the governor on October 16, 2025, so it did not become law.
Establishes a state frontotemporal degeneration registry; defines terms; requires every physician, nurse practitioner, nurse physician assistant and general hospital that diagnoses or is treating a patient diagnosed with an FTD disorder to give notice to the department; requires certain information to be confidential; sets forth the duties of the commissioner of health; requires the department of health to create and maintain a webpage.
This bill requires medical evaluations for assisted living facility admission to be completed within 30 days before a resident's move-in date. It directly affects assisted living facilities and prospective residents, mandating that evaluations must be signed by a physician, physician assistant, or nurse practitioner. The key provision updates eligibility rules to ensure assessments reflect current health needs. This change aims to improve safety and appropriateness of care placements by requiring timely evaluations. (4 sentences)
New York's S 3362 repeals Section 3372 of the Public Health Law, which previously required healthcare practitioners to report patients' drug use to authorities. This change directly affects doctors, nurses, and other medical professionals who previously had this reporting obligation. The bill removes the specific legal requirement for practitioners to document and submit such information about patient substance use. The repeal simplifies administrative duties for healthcare providers but does not alter other patient privacy protections or drug-related regulations.
Requires that health insurance policies shall provide coverage for follow-up screening or diagnostic services for lung cancer; provides that no patient cost sharing shall be imposed for follow-up screening or diagnostic services for lung cancer.